{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T18:03:02Z","timestamp":1764093782710,"version":"3.45.0"},"reference-count":12,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2015,7]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>Human papillomavirus (HPV) vaccination has been reimbursed in Belgium since 2007 for girls (12\u201315 years), extended to girls up to 18 years in 2008. This study assesses the trend of HPV 16\/18 infections in women less than 25 years of age participating in opportunistic cervical cancer screening. A significant reduction in the prevalence of HPV 16 [relative risk (RR)=0.61, 95% confidence interval=0.39\u20130.95] and a nonsignificant reduction in HPV 18 (RR=0.65, 95% confidence interval=0.29\u20131.48) was found in the youngest group (15\u201319 years). The prevalences in the older age group did not change significantly. These findings show the early effects of HPV vaccination and confirm the effectiveness of immunization in a real-life setting.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/cej.0000000000000067","type":"journal-article","created":{"date-parts":[[2014,8,12]],"date-time":"2014-08-12T05:42:44Z","timestamp":1407822164000},"page":"340-342","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":11,"title":["Early effects of human papillomavirus vaccination in Belgium"],"prefix":"10.1097","volume":"24","author":[{"given":"Mireille","family":"Merckx","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Davy Vanden","family":"Broeck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ina","family":"Benoy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christophe","family":"Depuydt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven","family":"Weyers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc","family":"Arbyn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-11-20251125","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1016\/S0959-8049(00)00308-7","article-title":"Cervical cancer screening in Belgium","volume":"36","author":"Arbyn","year":"2000","journal-title":"Eur J Cancer"},{"key":"R2-11-20251125","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1159\/000314010","article-title":"Introduction of human papillomavirus vaccination in Belgium, Luxembourg and the Netherlands","volume":"70","author":"Arbyn","year":"2010","journal-title":"Gynecol Obstet Invest"},{"key":"R3-11-20251125","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1002\/ijc.27650","article-title":"EUROGIN 2011 roadmap on prevention and treatment of HPV-related disease","volume":"131","author":"Arbyn","year":"2012","journal-title":"Int J Cancer"},{"key":"R4-11-20251125","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/sj.bjc.6601024","article-title":"Comparison of HPV type distribution in high-grade cervical lesions and cervical cancer: a meta-analysis","volume":"89","author":"Clifford","year":"2003","journal-title":"Br J Cancer"},{"key":"R7-11-20251125","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/S1473-3099(12)70187-1","article-title":"Cross-protective efficacy of two human papillomavirus vaccines: a systematic review and meta-analysis","volume":"12","author":"Malag\u00f3n","year":"2012","journal-title":"Lancet Infect Dis"},{"key":"R8-11-20251125","first-page":"655","article-title":"High-throughput detection, genotyping and quantification of the human papillomavirus using real-time PCR","volume":"50","author":"Micalessi","year":"2011","journal-title":"Clin Chem Lab Med"},{"key":"R9-11-20251125","doi-asserted-by":"crossref","first-page":"370","DOI":"10.2307\/2344614","article-title":"Generalized linear models","volume":"135","author":"Nelder","year":"1972","journal-title":"J R Stat Soc A"},{"key":"R10-11-20251125","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0140-6736(09)61248-4","article-title":"Efficacy of human papillomavirus (HPV)-16\/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women","volume":"374","author":"Paavonen","year":"2009","journal-title":"Lancet"},{"key":"R11-11-20251125","doi-asserted-by":"crossref","first-page":"9148","DOI":"10.1016\/j.vaccine.2011.09.115","article-title":"Cervical adenocarcinoma: moving towards better prevention","volume":"29","author":"Seoud","year":"2011","journal-title":"Vaccine"},{"key":"R12-11-20251125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2807\/ese.14.46.19407-en","article-title":"Introduction of human papillomavirus (HPV) vaccination in Belgium, 2007\u20132008","volume":"14","author":"Simoens","year":"2009","journal-title":"Euro Surveill"},{"key":"R13-11-20251125","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/path.1866","article-title":"HPV-mediated cervical carcinogenesis: concepts and clinical implications","volume":"208","author":"Snijders","year":"2006","journal-title":"J Pathol"},{"key":"R15-11-20251125","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/S1470-2045(11)70287-X","article-title":"Cross-protective efficacy of HPV-16\/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by non-vaccine oncogenic HPV types: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial","volume":"13","author":"Wheeler","year":"2012","journal-title":"Lancet Oncol"}],"container-title":["European Journal of Cancer Prevention"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00008469-201507000-00011","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T18:00:10Z","timestamp":1764093610000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00008469-201507000-00011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":12,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1097\/cej.0000000000000067","relation":{},"ISSN":["0959-8278"],"issn-type":[{"type":"print","value":"0959-8278"}],"subject":[],"published":{"date-parts":[[2015,7]]}}}